Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Barbara Burtness MD
Barbara Burtness MD Advisory Board
Lee Schwartzberg MD, FACP
Lee S. Schwartzberg MD, FACP Advisory Board
Benjamin Anderson MD, FACS
Benjamin O. Anderson MD, FACS Advisory Board
See All Experts
story of the week
Published in Oncology

Journal Scan / Research · April 17, 2014

Chemotherapy With or Without Cetuximab in Liver Metastasis From CRC

The Lancet Oncology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Axel Grothey MD

The Lancet Oncology
Systemic Chemotherapy With or Without Cetuximab in Patients With Resectable Colorectal Liver Metastasis: The New EPOC Randomised Controlled Trial
Lancet Oncol 2014 May 01;15(6)601-11, J Primrose, S Falk, M Finch-Jones, J Valle, D O'Reilly, A Siriwardena, J Hornbuckle, M Peterson, M Rees, T Iveson, T Hickish, R Butler, L Stanton, E Dixon, L Little, M Bowers, S Pugh, OJ Garden, D Cunningham, T Maughan, J Bridgewater

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated